MedPath

Investigation of the safety and effectiveness of fractional CO2 laser in combination with topical minoxidil 15% in the treatment of patients with androgenetic hair loss.

Phase 1
Recruiting
Conditions
Androgenetic alopecia.
Androgenic alopecia, unspecified
L64.9
Registration Number
IRCT20200127046282N50
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Not using topical or oral medication for the treatment of alopecia during the last six months
AGA type 2-4

Exclusion Criteria

Age under18 years
pregnancy
breastfeeding
History of malignant diseases
Taking any topical or systemic treatment during the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath